ARK Investment Management’s Zymergen Inc. Common Stock ZY Stock Holding History

ARK Investment Management’s Portfolio ZY Stock Details ZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-7,482,047	Closed	-$20.8M	–	253
2022 Q3	$20.8M	Buy	7,482,047 +4,025,529	+116%	+$9.77M	0.15%	81
2022 Q2	$4.91M	Buy	3,456,518 +318,171	+10%	+$533K	0.03%	143
2022 Q1	$9.07M	Sell	3,138,347 -114,049	-4%	-$484K	0.04%	138
2021 Q4	$21.8M	Sell	3,252,396 -530,105	-14%	-$5.15M	0.07%	134
2021 Q3	$49.8M	Buy	3,782,501 +2,684,290	+244%	+$57M	0.12%	115
2021 Q2	$43.9M	Buy	+1,098,211	New	+$43.3M	0.08%	132

ARK Investment Management's ZY Position: Q4 2022 in Review

ARK Investment Management sold out of Zymergen Inc. Common Stock (ZY) in Q4 2022, closing a stake of 7,482,047 shares — an estimated $20.8M sold.

ARK Investment Management first reported a position in ZY in Q2 2021 and held it in 6 quarters. The position peaked at $49.8M in Q3 2021. 0 funds tracked by Wall St. Rank hold ZY as of Q4 2022.

ARK Investment Management reported no remaining Zymergen Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
ARK Investment Management sold 7,482,047 Zymergen Inc. Common Stock shares in Q4 2022, an estimated $20.8M.
ARK Investment Management first reported a position in Zymergen Inc. Common Stock in Q2 2021 and held it in 6 quarters.
ARK Investment Management's Zymergen Inc. Common Stock position peaked at $49.8M in Q3 2021.
0 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q4 2022.

Based on ARK Investment Management's 13F filing for Q4 2022, filed 24 Jan 2023.